Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Su-Liang Li"'
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundPrevious studies have shown that miR-100-5p expression is abnormal in prostate cancer. However, the role and regulatory mechanism of miR-100-5p requires further investigation. Thus, the aim of this study was to observe the effects of miR-10
Externí odkaz:
https://doaj.org/article/f54784a90af4492c9cde7f2a556ef182
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0198055 (2018)
PURPOSE:Prostate cancer (PCa) causes a common male urinary system malignant tumour, and the molecular mechanisms of PCa are related to the abnormal regulation of various signalling pathways. An increasing number of studies have suggested that mRNAs,
Externí odkaz:
https://doaj.org/article/c03ab40e40c24ab0b56bee695bd5bc41
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0171081 (2017)
A number of studies have investigated the effect of perioperative blood transfusion (PBT) for patients after radical prostatectomy (RP), with some reporting conflicting results. A systematic review of the literature and a meta-analysis were conducted
Externí odkaz:
https://doaj.org/article/bbab7471ddc2456996e4a1cf1a74784e
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 29, Iss 10, Pp 547-553 (2013)
The study aimed to evaluate the levels of serum free kappa (κ) and lambda (λ) light chains in patients with rheumatoid arthritis (RA) as well as exploring the association between serum free κ and λ light chains and activity of RA. For this purpos
Externí odkaz:
https://doaj.org/article/6c41c1fbef8643cdb4a952ec024fc677
Publikováno v:
Blood and Genomics. 4:53-59
Autor:
Yun Ye, Xiao-Hua Yuan, Jian-Jun Wang, Yu-Chen Wang, Su-Liang Li, Ye, Yun, Yuan, Xiao-Hua, Wang, Jian-Jun, Wang, Yu-Chen, Li, Su-Liang
Publikováno v:
Medicine; 5/29/2020, Vol. 99 Issue 22, p1-8, 8p
Autor:
Zhuo Li, Mingquan Su, Yi Xu, Wei-Xiao Fan, Yun Ye, Yang Ji, Juan Wang, La-Xiu Li, Su-Liang Li, Yueyun Ma, Yanjun Diao, Liu Yang, Lin Lei, Xiaoke Hao
Publikováno v:
Oncotarget
// Yun Ye 1, 2, * , Su-Liang Li 2, * , Yue-Yun Ma 1 , Yan-Jun Diao 1 , Liu Yang 1 , Ming-Quan Su 1 , Zhuo Li 2 , Yang Ji 3 , Juan Wang 1 , Lin Lei 1 , Wei-Xiao Fan 1 , La-Xiu Li 1 , Yi Xu 1 and Xiao-Ke Hao 1 1 Department of Laboratory Medicine, Xijin
BackgroundRASSF1A promoter methylation is consistent with clinicopathological data and has good accuracy in distinguishing tumors. However, the diagnostic parameters vary among previous studies. A systematic review was conducted to explore the diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e6fa217ff945e423173dbe969aaa171
https://doi.org/10.1101/2020.07.15.204024
https://doi.org/10.1101/2020.07.15.204024
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
BackgroundPrevious studies have shown that miR-100-5p expression is abnormal in prostate cancer. However, the role and regulatory mechanism of miR-100-5p requires further investigation. Thus, the aim of this study was to observe the effects of miR-10
Publikováno v:
Medicine. 99(22)
Background miR-141 has gradually demonstrated its value in the diagnosis of prostate cancer. However, the diagnostic parameters in previous studies differ. A systematic review was conducted to explore the diagnostic value of miR-141 in prostate cance